Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.25%
#2 Pons Pons +44.07%
#3 Mubarak Mubarak +38.95%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.27%
#5 Starpower Starpower +28.10%
#6 SkyAI SkyAI +24.07%
#7 TENDIES TENDIES +23.33%
#8 Decred Decred +20.80%
#9 Degen (Base) Degen (Base) +20.08%
#10 StonkBroker StonkBroker +18.13%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Sofiva Genomics Co.,Ltd. Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co.,Ltd.

6615
Rang în acțiuni #29070
Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan,... Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan, offers a comprehensive range of genetic testing services to both domestic and international clients. The company's diverse diagnostic solutions are designed to support expectant parents, individuals with inherited conditions, and their families. Their extensive prenatal diagnostics include screenings for conditions such as thalassemia carrier status, various microdeletion syndromes, single-gene abnormalities, common chromosomal anomalies, and specific skeletal dysplasia mutations. They also provide multi-gene panel testing for inherited diseases, folate metabolism genetic analysis, carrier screening for spinal muscular atrophy (SMA) and Fragile X syndrome, congenital infection detection, preeclampsia risk assessment, maternal serum screening for Down syndrome, and karyotyping. Within the oncology sector, Sofiva Genomics delivers advanced cancer screenings, dynamic monitoring of tumor activity, and genetic evaluations for hereditary cancer predisposition. This includes specialized panels for women's cancers (breast, colon, ovarian, and endometrial), alongside human papillomavirus (HPV) screening. Furthermore, the company conducts genetic testing for rare diseases and provides specialized reproductive services such as preimplantation genetic diagnosis (PGD) and next-generation sequencing (NGS)-based preimplantation genetic screening (PGS). For newborns, their services encompass comprehensive "baby scans," screenings for hereditary sensorineural hearing loss, congenital central hypoventilation syndrome (CCHS), congenital cytomegalovirus (CMV) infection, and genetic risk assessment for atopic dermatitis. Beyond these specialized offerings, Sofiva Genomics also performs biochemical and chromosomal analyses, complemented by valuable advisory and support services for its clientele.
Preț acțiune
$1.07
Capitalizare de piață
$23.11M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
4.66%
Țară
TW
Tranzacționează Sofiva Genomics Co.,Ltd. (6615)

Categorie

Healthcare
Istoricul randamentului dividendelor pentru Sofiva Genomics Co.,Ltd. (6615)
Randamentul dividendelor (TTM) pentru Sofiva Genomics Co.,Ltd. (simbol acțiune: 6615) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Sofiva Genomics Co.,Ltd. (6615) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
Nu sunt suficiente date pentru perioada selectată.
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
0.31%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
0.71%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
0.00%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
0.00%
US